Curis CRIS
NASDAQ CRIS
$1.58 -0.03 (-1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

Curis (CRIS) Cash & Current Investments (2010 - 2026)

Curis' (CRIS) quarterly Cash & Current Investments came in at $15.0 million in Q1 2026, down 26.04% YoY from $20.3 million in Q1 2025, and up 196.4% on a QoQ basis from $5.1 million in Q4 2025.

Curis (CRIS) Cash & Current Investments (2010 - 2026) Analysis & Trends

Curis (CRIS) has 17 years of Cash & Current Investments data on file, last reported at $15.0 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 26.04% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (down 26.04% YoY) and the FY2025 annual result came in at $5.1 million, down 74.69% from the prior year.
  • Cash & Current Investments grew to $15.0 million in Q1 2026, from $5.1 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $120.7 million in Q1 2022 to a low of $5.1 million in Q4 2025.
  • A 5-year average of $49.5 million and a median of $40.7 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments fell 22.86% — and 2025, when it slumped 74.69%.
  • Tracing CRIS's Cash & Current Investments over 5 years: stood at $85.6 million in 2022, then sank by 34.21% to $56.3 million in 2023, then slumped by 64.5% to $20.0 million in 2024, then tumbled by 74.69% to $5.1 million in 2025, then surged by 196.4% to $15.0 million in 2026.
  • The last three Cash & Current Investments figures came in at $15.0 million (Q1 2026), $5.1 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Curis 3.27 Mn -2.35 Mn - 5.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.00 Mn
Dec 31, 2025 5.06 Mn
Sep 30, 2025 9.05 Mn
Jun 30, 2025 10.14 Mn
Mar 31, 2025 20.28 Mn
Dec 31, 2024 20.00 Mn
Sep 30, 2024 20.85 Mn
Jun 30, 2024 28.36 Mn
Mar 31, 2024 40.72 Mn
Dec 31, 2023 56.33 Mn
Sep 30, 2023 68.50 Mn
Jun 30, 2023 63.49 Mn
Mar 31, 2023 71.76 Mn
Dec 31, 2022 85.62 Mn
Sep 30, 2022 98.69 Mn
Jun 30, 2022 107.20 Mn
Mar 31, 2022 120.65 Mn
Dec 31, 2021 115.88 Mn
Sep 30, 2021 128.90 Mn
Jun 30, 2021 152.57 Mn